KRKA, TOVARNA ZDRAVIL, D.D. , NOVO MESTO Patent applications |
Patent application number | Title | Published |
20130177652 | PHARMACEUTICAL ORAL DOSAGE FORMS COMPRISING DABIGATRAN ETEXILATE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS - The invention relates to pharmaceutical oral dosage forms of the active substance ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate (dabigatran etexilate) and the pharmacologically acceptable salts thereof, in particular dabigatran etexilate methanesulfonate. | 07-11-2013 |
20120283291 | SOLID PHARMACEUTICAL COMPOSITION COMPRISING DONEPEZIL HYDROCHLORIDE - The invention relates to a solid pharmaceutical composition comprising donepezil hydrochloride hydrate and a process for its preparation. In particular it relates to a composition and a process wherein the donepezil hydrochloride retains its polymorphic form and is therefore highly stable against conversion into other polymorphic forms. | 11-08-2012 |
20100317694 | Solid pharmaceutical composition comprising donepezil hydrochloride - The invention relates to a solid pharmaceutical composition comprising donepezil hydrochloride hydrate and a process for its preparation. In particular it relates to a composition and a process wherein the donepezil hydrochloride retains its polymorphic form and is therefore highly stable against conversion into other polymorphic forms. | 12-16-2010 |
20100298400 | SALTS OF PERINDOPRIL - The present invention relates to new salts of perindopril, particularly to a new calcium salt and new amine salts of perindopril, to a process for their preparation and to a pharmaceutical formulations containing the new salts. | 11-25-2010 |
20100143460 | SOLID DOSAGE FORMS COMPRISING ALISKIREN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF - The present invention relates to a pharmaceutical formulation comprising aliskiren or a pharmaceutically acceptable salt thereof as the active ingredient, wherein the pharmaceutical formulation is present in a solid dosage form suitable for oral administration based on a granulate obtained by a hot-melt and solvent-free granulation process, and to a process for manufacturing a pharmaceutical formulation. | 06-10-2010 |
20100105908 | Process For The Preparation Of Levocetirizine And Intermediates Thereof - The present invention describes a novel process for the preparation of levocetirizine and pharmaceutically acceptable acid addition salts thereof using diglycolic acid or derivatives thereof and new intermediates used in that process. | 04-29-2010 |
20090234123 | Processes For The Preparation Of Clopidogrel Hydrogen Sulfate Polymorphic Form I - Processes for the preparation of clopidogrel hydrogen sulfate of polymorphic form I are described which include use of specific solvents and process measures to avoid formation of undesired by-products. | 09-17-2009 |
20090130205 | Solid Pharmaceutical Composition Comprising Donepezil Hydrochloride - The invention relates to a solid pharmaceutical composition comprising donepezil hydrochloride hydrate and a process for its preparation. In particular it relates to a composition and a process wherein the donepezil hydrochloride retains its polymorphic form and is therefore highly stable against conversion into other polymorphic forms. | 05-21-2009 |